NCT02684227 2025-03-19
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
3 trialsNCT01974765 2023-04-28
Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03464201 2023-02-22
GREKO III
Grupo EspaƱol de Tumores HuƩrfanos e Infrecuentes
Phase 2 Completed